CalciMedica, Inc.
For the period ended Aug 19, 2026. Filed Jul 23, 2026.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Aug 19, 2026 · Filed Jul 23, 2026
Contents
APPENDIX A
CALCIM EDICA, INC.
2023 EQUITY INCENTIVE PLAN
ADOPTED BY THE BOARD OF DIRECTORS: FEBRUARY 5, 2023
APPROVED BY THE STOCKHOLDERS: MARCH 15, 2023
AMENDED BY THE BOARD OF DIRECTORS: MARCH 28, 2024
APPROVED BY THE STOCKHOLDERS: AUGUST 27, 2024
AMENDED BY THE BOARD OF DIRECTORS: APRIL 23, 2025
APPROVED BY THE STOCKHOLDERS: JUNE 24, 2025
AMENDED BY THE BOARD OF DIRECTORS: JULY 20, 2026
APPROVED BY THE STOCKHOLDERS: , 2026
TABLE OF CONTENTS
| Page | |||
| 1. | GENERAL | A-1 | |
| 2. | SHARES SUBJECT TO THE PLAN | A-1 | |
| 3. | ELIGIBILITY AND LIMITATIONS | A-2 | |
| 4. | OPTIONS AND STOCK APPRECIATION RIGHTS | A-3 | |
| 5. | AWARDS OTHER THAN OPTIONS AND STOCK APPRECIATION RIGHTS | A-6 | |
| 6. | ADJUSTMENTS UPON CHANGES IN COMMON STOCK; OTHER CORPORATE EVENTS | A-8 | |
| 7. | ADMINISTRATION | A-9 | |
| 8. | TAX WITHHOLDING | A-11 | |
| 9. | MISCELLANEOUS | A-12 | |
| 10. | COVENANTS OF THE COMPANY | A-15 | |
| 11. | ADDITIONAL RULES FOR AWARDS SUBJECT TO SECTION 409A | A-15 | |
| 12. | SEVERABILITY | A-18 | |
| 13. | TERMINATION OF THE PLAN | A-18 | |
| 14. | DEFINITIONS | A-18 | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.